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Abstract
Background: There is increasing evidence for the role of prenatal stress in shaping offspring DNA methylation and
disease susceptibility. In the current study, we aimed to identify genes and pathways associated with pregnancy
anxiety using a genome-wide DNA methylation approach.
Methods: We selected 22 versus 23 newborns from our Prenatal Early Life Stress (PELS) cohort, exposed to the lowest
or highest degree of maternal pregnancy anxiety, respectively. Cord blood genome-wide DNA methylation
was assayed using the HumanMethylation450 BeadChip (HM450, n = 45) and candidate gene methylation
using EpiTYPER (n = 80). Cortisol levels were measured at 2, 4, and 12 months of age to test infant stress
system (re)activity.
Results: Data showed ten differentially methylated regions (DMR) when comparing newborns exposed to low
versus high pregnancy anxiety scores. We validated a top DMR in the GABA-B receptor subunit 1 gene (GABBR1) revealing
the association with pregnancy anxiety particularly in male newborns (most significant CpG Pearson R = 0.517, p = 0.002;
average methylation Pearson R = 0.332, p = 0.039). Cord blood GABBR1 methylation was associated with infant cortisol
levels in response to a routine vaccination at 4 months old.
Conclusions: In conclusion, our results show that pregnancy anxiety is associated with differential DNA methylation
patterns in newborns and that our candidate gene GABBR1 is associated with infant hypothalamic-pituitary-adrenal axis
response to a stressor. Our findings reveal a potential role for GABBR1 methylation in association with stress and provide
grounds for further research.
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Background
Prenatal stress exposure can adversely influence infant
development and alter susceptibility to obesity, meta-
bolic disorders, and mental health outcomes [1]. Al-
though the exact mechanisms of such links between the
prenatal environment and postnatal (e.g., behavioral)
phenotype are still unknown, many recent studies found
evidence of a potential role for DNA methylation. Differ-
ent forms and severity of maternal psychosocial stress
were found to have an influence on fetal DNA methyla-
tion patterns [2]. Epigenetic studies investigating mater-
nal well-being during pregnancy have largely made use
of candidate gene approaches. For instance, gene-
specific DNA methylation changes associated with
prenatal stress were found in the glucocorticoid receptor
gene (NR3C1) [3]. More specifically, studies showed
associations of infant NR3C1 DNA methylation with
maternal depressive symptoms [4–6], exposure to inter-
partner violence [7], and war stress [8, 9]. A link of
NR3C1 DNA methylation and altered infant stress
reactivity of the hypothalamic-pituitary-adrenal (HPA)
axis was found in the study of Oberlander et al. [4].
DNA methylation of other candidate genes with a role
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in HPA axis [6, 9] or immune system function [10] was
associated with prenatal stress as well.
In addition to these candidate gene approaches, some
epigenome-wide association studies (EWAS) have exam-
ined the potential role of prenatal stress. Genome-wide
DNA methylation changes have been found in newborns
from women with non-medicated depression or anxiety
during pregnancy [11], while another study shows an
association between the methyltransferase pathway and
prenatal stress in two population-based cohorts [12].
Contrasting maternal perceived stress and objective
measurements of hardship, Cao-Lei and colleagues
found that only the latter was associated with DNA
methylation at several CpG sites of children in the Pro-
ject Ice Storm study [2]. Furthermore, a recent study by
Serpeloni et al. described genome-wide DNA methyla-
tion changes associated with grandmaternal exposure to
violence during pregnancy [13].
In previous publications examining our specific birth
cohort, we have shown that pregnancy anxiety appeared
to be an important factor associated with DNA methyla-
tion changes of the NR3C1 gene [14] and two imprinted
genes involved in fetal development, i.e., insulin-like
growth factor 2 (IGF2) and guanine nucleotide binding
protein, alpha stimulating (GNAS) in cord blood [15].
These studies provide evidence that not only extreme
forms of prenatal stress such as exposure to war or
natural disasters [2, 8] but also maternal anxiety in a
general healthy population, can alter DNA methylation
in the offspring.
Following up on our candidate gene studies, we here
performed an EWAS to identify the DNA methylation
changes in newborns associated with maternal pregnancy-
related anxiety. This hypothesis-generating approach pro-
vides the opportunity to identify novel candidate genes
but also to study interactions using a biological pathway
analysis. The magnitude of one of our EWAS discovery
findings was subsequently investigated in an extended
sample set using a different DNA methylation quantifica-
tion technique, the Sequenom EpiTYPER platform.
Finally, we examined the association of DNA methylation
at our candidate region with infant HPA axis function.
Methods
Study population
Between October 2009 and December 2010, samples
from 170 highly educated pregnant women at 6 to
12 weeks of gestation were recruited within the Prenatal
Early Life Stress (PELS) study in the University Hospitals
Leuven, Belgium. A detailed description of data and
sample collection can be found elsewhere [14].
Briefly, each trimester, the pregnant women completed
several questionnaires regarding mental health and gen-
eral well-being. From 80 of these 170 participating
mothers, we were able to collect a cord blood sample at
birth, of which DNA was subsequently isolated. Of these
80 samples, 45 DNA samples were selected for genome-
wide DNA methylation analysis based on maternal psy-
chological measurements, while all 80 DNA samples
were subsequently used for the candidate gene confirm-
ation study. A schematic overview of the study design is
represented in Additional file 1: Figure S1.
Psychological measurements
At each trimester of pregnancy, future mothers were
asked to complete questionnaires assessing depression,
anxiety, and mother-fetus relationship. The revised
pregnancy-related anxiety questionnaire (PRAQ) was used
to assess worries and anxiety specifically regarding the
participating mother’s pregnancy [16]. The validated re-
vised version, which we used for the current study, con-
tains three subscales: (1) fear of integrity of the fetus, (2)
concerns about one’s own appearance, and (3) fear of the
delivery itself [17]. We previously reported a high internal
reliability for the total scale (Cronbach’s α ≥ 0.95) and
good internal reliability for the subscales (Cronbach’s
α ≥ 0.73) of the revised questionnaire [14]. To select the
samples for EWAS, we focused on the fear of integrity
subscale of PRAQ, which appeared as most associated
with DNA methylation in our candidate gene studies [14,
15]. This subscale provides a score ranging from zero to
seven and measures maternal anxiety regarding the health
of the unborn infant and fear of integrity of the newborn.
Child HPA axis measurements
In order to measure infant HPA axis stress response as
well as baseline activity, cortisol was measured in response
to a vaccination at 2 and 4 months old and during the day
at 12 months old. In both vaccination studies and the day
profile study, saliva samples for cortisol measurements
were taken using BD Visitec eye sponges (Becton, Dickson
and Company, Waltham, USA). To determine cortisol
levels in saliva a High Sensitivity Salivary Cortisol Enzyme
Immunoassay Kit (ELISA kit, Salimetrics, Europe) was
used. This assay captures the full range of salivary cortisol
levels (0.003 to 3.0 μg/dL) while using only 25 μL of saliva
per test and it was designed by Salimetrics to be resilient
to the effects of interference caused by collection tech-
niques that affect pH.
Cortisol was measured in response to a physical stressor
at 2 and 4 months of age. All visits were scheduled in the
afternoon to control for circadian rhythm. Mothers were
asked not to feed their infants from 1 hour before the test
until after the test since this might compromise assay per-
formance by lowering sample pH and influencing bacterial
growth. The routine vaccination consisted of two intra-
muscular injections: one injection for Pneumococcus and
one combined injection for diphtheria, whooping cough,
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tetanus, poliomyelitis, and Haemophilus influenza type B.
Saliva for cortisol measurements was collected at arrival
to the examination room and at 15, 30, 45, and 60 min fol-
lowing the injection. The time between arrival and vaccin-
ation included the time when the parent undressed the
infant, when both waited for the doctor to arrive, and
when the doctor was taking the health history and the
physical examination. The use of this vaccination stressor
has a number of advantages: (1) it is routinely performed
on all infants and therefore is convenient; (2) it is stan-
dardized, and so equal treatment to all infants can be as-
sumed (especially if all the data are collected at the same
facility); (3) the onset of the application of the aversive
stimulation can be precisely determined; and (4) the in-
oculation is aversive enough to evoke behavioral distress
[18]. The maximum value following vaccination was noted
and the area under the curve with respect to increase
(AUCi), initial response (value at 15 min minus baseline),
and recovery slope (value at 60 min minus 15 min) were
calculated. Data for several of these variables were skewed
(Shapiro-Wilk p value < 0.05) and were logit transformed
to correct skewness. If measurements for one-time point
were missing, AUCi, initial response and recovery slope
were not calculated for this individual.
When infants were 12 months of age, mothers were
instructed to collect saliva samples of their infant at
awakening, 30 min, 4, and 12 h after awakening. Samples
were sent back to our lab in a prepaid, addressed enve-
lope, and processed to measure cortisol levels. The corti-
sol awakening response (CAR) was calculated and a
repeated t test was carried out to verify a significant cor-
tisol increase between awakening and 30 min.
Illumina Infinium HumanMethylation450 BeadChip Assay
Cord blood DNA samples were processed by the Barts
and the London Genome Centre (London, UK), where bi-
sulfite treatment was carried out using the Zymo EZ DNA
methylation kit (Zymo Research) prior to running the Infi-
nium HumanMethylation450 BeadChip (HM450) arrays
(Illumina Inc., California, USA). In total, 48 samples were
randomized over four chips based on PRAQ score, mater-
nal smoking, maternal alcohol use, gender of the newborn,
parity and gravidity, gestational age at birth, and maternal
age. One sample was replicated on each chip to account
for batch effects [19], resulting in a sample size of 45
unique samples analyzed on the HM450 array.
Data processing and quality control
Raw data generated by the iScan Illumina array were
imported using GenomeStudio software (Illumina, Inc.)
and the subsequent quality control and normalization
were implemented using the wateRmelon package in R
(available from the Bioconductor repository http://
www.bioconductor.org) [20]. Data clean-up included
removal of samples and CpG probes with insufficient data
quality. In more detail, samples were removed if more than
5% of its sites had a poor detection p value (> 0.01), and
probes with a detection p value of more than 0.01 in more
than 1% of samples or a bead count of less than 3 in more
than 5% of samples were removed from the analysis. Fur-
thermore, cross-hybridizing probes, probes containing a
common single nucleotide polymorphism (SNP) in the se-
quence or within 10 bp of the sequence, and probes on the
X and Ychromosomes were removed [21]. The final analysis
included 414,733 probes, and all samples passed the strin-
gent quality control. A schematic overview of the analysis
from data preprocessing until validation can be found in the
Supplementary information (Additional file 1: Figure S1).
Genome-wide DNA methylation analysis
Differentially methylated regions (DMRs) were first ex-
plored using the R package DMRcate [22]. The DMRcate
statistical model was corrected for gender, gestational age
of the newborn at birth, batch (chip Sentrix ID), and cell
type compositions as calculated with the Houseman algo-
rithm [23]. Using the top 500 uniquely annotated DMRs
from DMRcate, we performed a pathway analysis. Enrich-
ment for Gene Ontology (GO) classes was conducted using
the over-representation analysis (ORA) method in ErmineJ
with a minimum gene set of 5, and a maximum of 100 [24].
DMR verification and validation using Sequenom
EpiTYPER
In order to verify the top DMRs from the DMRcate ana-
lysis, we used a second region-specific method: the Python
module comb-p [25]. Comb-p employs probe locations
and p values from the differentially methylated CpG probe
(DMP) analysis as input to identify differentially methyl-
ated regions. We, therefore, first calculated DMPs using a
linear regression model with pregnancy anxiety as a
categorical measurement (high versus low) corrected for
gender, gestational age of the newborn, batch (chip Sentrix
ID) effects, and cell type compositions, similar to the
DMRcate model. A list of DMPs was further used for
comb-p DMR analysis. Both comb-p and DMRcate have
distinct underlying statistical methods to identify DMRs.
DMRcate runs a model using a kernel smoothing function
on logit-transformed beta values (“M values”), indepen-
dently from the single CpG site significance. Comb-p, on
the contrary, identifies DMRs based on the output of a
probe-by-probe analysis, i.e., using the DMP analysis p
values and locations of each CpG probe. Both methods
calculate DMRs only accounting for their location in the
genome, i.e., non-annotated. We combined their results to
rank DMRs and further use this ranking to select candi-
date genes. To statistically test the overlap of unique,
protein-coding genes between DMRcate and comb-p lists,
the R package GeneOverlap (Bioconductor) was used [26].
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Based on the HM450-identified DMR, an amplicon of
446 base pairs was designed using EpiDesigner. A sche-
matic overview and the genomic sequence of the ampli-
con located at chr6:29594930–29595375 (hg19; forward
primer: GGTTAGGGGGTTAGGTTTGTTAGTT; re-
verse primer: ACTCCCTCAAAAAATCAATATCTCC)
can be found in Additional file 1: Figure S2. In silico ana-
lysis, using the MassArray package in Bioconductor [27]
preceded laboratory experiments in order to assess (un)-
successful CpG units in advance [28]. EpiTYPER DNA
methylation analysis was performed for a total of 80 cord
blood samples (including 45 samples used for the HM450
analysis and 35 additional samples) of the PELS cohort as
described [15]. In short, cord blood DNA (1 μg) was bisul-
fite treated using the MethylDetector kit with long cycling
protocol (Active Motif, Carlsbad, CA, USA) [29]. Subse-
quently, amplicons were amplified in triplicate for each
sample, followed by T-cleavage reactions and detection by
mass spectrometry using the Sequenom MassARRAY
(San Diego, CA, USA) protocol. The signal was subse-
quently translated by the EpiTYPER software resulting in
DNA methylation percentages for each CpG unit. Values
were excluded if the standard deviation between triplicates
was more than 10%, and CpG units were excluded when
having a success rate of less than 70%. A summary of CpG
sites analyzed by EpiTYPER and their corresponding
HM450 CpG probe identifiers is shown in the Supplemen-
tary data (Additional file 2). For this part of the study, all
80 samples of our PELS cohort were used and, therefore,
PRAQ could be analyzed as a continuous variable. The
association of DNA methylation at each CpG unit with
PRAQ was analyzed using Pearson’s correlation tests.
SPSS Statistics, version 23 (IBM Corp., Armonk, NY,
USA) was used for these statistical analyses.
Results
Demographic data of the study cohort selected for EWAS
Cord blood DNA samples for the genome-wide methylation
analysis were selected from the 80 mother-infant dyads of
our PELS cohort. We aimed for the upper and lower quar-
tiles of PRAQ-integrity scores and included 23 mothers
with the highest and 22 mothers with the lowest scores.
All participating mothers were European, with a mean
maternal age of 30.6 years and an average length of gesta-
tion of 277.2 days. An overview of selected demographic
parameters and comparison between the high and low
pregnancy anxiety group can be found in Table 1.
Global DNA methylation is not influenced by pregnancy
anxiety
Global DNA methylation difference between the low
and the high prenatal anxiety group was assessed. We
compared DNA methylation of all long interspersed nu-
clear element (LINE) repeats by analyzing preprocessed
and normalized beta values at CpG probes in both
LINE-1 and LINE-2 repeats extracted from the HM450
data as described previously [30]. This analysis involved
15,612 CpG probes at LINE repeats localized throughout
the genome. The average DNA methylation percentage
for these repetitive elements was 68.58 versus 68.61% for
the high and low prenatal anxiety group, respectively.
Differentially methylated regions associated with
pregnancy anxiety
Because a region of nearby CpG sites that are differentially
methylated often provides stronger evidence for effective
transcriptional regulation, we investigated the presence of
DMRs using DMRcate. This method starts from prepro-
cessed, normalized methylation values to analyze the
HM450 data. DMRcate identified 901 DMRs with 3 or
more probes that were differentially methylated between
newborns exposed to high versus low pregnancy anxiety
(top 50 DMRs presented in Additional file 3).
Epigenome-wide pathway analysis was performed in
order to determine specific pathways, which are over-
represented. For this purpose, we used ErmineJ on the top
500 uniquely annotated DMRs from DMRcate, enabling
us to additionally assess multifunctionality of the resulting
GO terms. The top enriched pathways are shown in
Additional file 4, showing medium to high multifunction-
ality scores. Three of the top five GO terms relate to brain
development, i.e., “pallium development” (p = 0.001),
“hippocampus development” (p = 0.004), and “telenceph-
alon development” (p = 0.004). Other top GO terms seem
to be related to general cellular function and tight junc-
tions with multifunctionality scores ranging from 0.002 to
0.932 (Additional file 4).
GABBR1 DNA methylation is positively associated with
pregnancy anxiety in male newborns
We aimed at identifying a candidate gene to be further
investigated in a larger sample set that includes the full
PELS cohort (n = 80). For this purpose, we wanted to
strengthen the DMR identification analysis by applying
to our genome-wide data a second statistical method to
identify DMRs, namely comb-p. The latter, in contrast to
DMRcate, identifies DMRs based on the output of a
probe-by-probe analysis, using the location and p values
of DMPs. To this end, we first tested each CpG probe
for differential methylation between neonates exposed to
high or low pregnancy anxiety, while correcting for
batch effects, gestational age, gender of the newborn,
and cord blood cell type estimates (Additional file 5). In
total, 17,180 CpG sites were differentially methylated
with an unadjusted p value of < 0.05 (referred to as
“DMP”) between the low and high pregnancy anxiety
group. However, following the false discovery rate (FDR)
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correction for multiple testing none of the individual
probes remained significant.
Subsequently, the comb-p tool was applied, returning
ten DMRs (Table 2). Individual probes within the DMRs
identified by comb-p are highlighted in a Manhattan plot
(Fig. 1). The top ten DMRs according to the comb-p
method are presented in Table 2 with indication of the
rank order of the equivalent genomic region in the
DMRcate results. There was a significant overlap between
genes annotated to the DMRcate and comb-p lists, as
assessed by GeneOverlap (p = 3.4E-7). The combined
ranking of both comb-p and DMRcate DMR analyses
identified homeobox C4 (HOXC4), palmitoyl-protein
thioesterase 2 (PPT2) and GABA-B receptor subunit 1
gene (GABBR1) as top three DMRs of interest with a max-
imum beta fold change (FC) of 0.044 (minimum comb-p
p = 1.8E-06, DMRcate p = 5.36E-14), 0.050 (minimum
comb-p p = 4.5E-05, DMRcate p = 5.43E-18), and 0.053
(minimum comb-p p = 0.00015, DMRcate p = 1.08E-08),
respectively. Contrary to HOXC4 and PPT2, GABBR1
DMR is located within a CpG island near active regulatory
elements (Additional file 1: Figure S2) and was therefore
selected for our validation study with Sequenom EpiTY-
PER. DNA methylation levels for each HM450 CpG probe
in the GABBR1 DMR identified by DMRcate, including
percent methylation difference between both groups
(range 0.24 to 4) and effect sizes (range 0.170 to 0.825)
can be found in Additional file 6.
An overview of the GABBR1 gene and the region ana-
lyzed by Sequenom EpiTYPER platform can be found in
Additional file 1: Figure S2. A summary of CpG units
analyzed or excluded for technical reasons is shown in
Additional file 2 and correlations between EpiTYPER and
HM450 probes are shown in Additional file 7. The 17
CpG sites present in the GABBR1 DMR corresponded to
14 CpG units, of which 4 could not be analyzed due to
technical reasons inherent to the MassArray and EpiTY-
PER methodology (e.g., low mass, fragment overlap) and
Table 1 Study cohort for the genome-wide DNA methylation analysis with low versus high maternal pregnancy anxiety (PRAQ): fear
of integrity scores
Low pregnancy anxiety High pregnancy anxiety
n = 22 n = 23 Test statistic p value
Pregnancy anxiety (PRAQ score) 2.1 (0.4) 5.2 (0.7) t = − 18.906 p < 0.0001
Maternal age (years (SD)) 30.0 (2.5) 31.1 (4.0) t = − 1.115 0.27
Paternal age (years (SD)) 32.0 (4.0) 32.5 (4.6) t = − 0.397 0.69
Single parenthood, n (%) 0 1 (4.3%) Fisher’s exact 1
Method of birth, (n cesarean section (%)) 2 (9.1%) 8 (34.8%) Fisher’s exact 0.07
Maternal BMI before pregnancy (kg/m2) 23.3 (3.5) 23.4 (4.3) t = − 0.478 0.64
Maternal smoking, n (%) 2 (9.1) 0 Fisher’s exact 0.23
Maternal alcohol use, n (%) 2 (9.1) 4 (17.4) Fisher’s exact 0.67
Gender of the baby, female n (%) 11 (50) 10 (43.5) Chi squared = 0.192 0.77
Gestational age (days (SD)) 277.3 (7.2) 277.1 (10.2) t = 0.071 0.94
Birth weight (g (SD)) 3544.1 (426.1) 3293.5 (447.2) t = 1.923 0.06
Table 2 Comb-p determined differentially methylated regions (DMR)
Rank
comb-p
Rank
DMRcate
RefGene
name
Location (GRCh37/hg19
assembly)
Minimum p
value
Number of
probes
Stouffer-Liptak-
Kechris p value
Šidák
corrected
CpG
island
1 624 TP53INP1 chr8:95962083–95962464 0 6 0 0 yes
2 NA PRSS50 chr3:46759334–46759699 0 8 0 0 yes
3 3 HOXC4 chr12:54446278–54446577 0 6 0 0 no
4 169 PKP3 chr11:396685–397078 0 3 0 0 yes
5 NA ZNF764 chr16:30572738–30573014 0 5 0 0 yes
6 2 PPT2 chr6:32120954–32121421 0 14 0 0 no
7 21 GABBR1 chr6:29595001–29595316 0 7 2.70E-07 0.07 yes
8 358 PITPNM3 chr17:6358362–6358600 0 4 2.88E-07 0.1 yes
9 NA ESRRG chr1:217306589–-217306764 0.01 3 1.01E-06 0.39 no
10 NA HS3ST2 chr16:22959593–22959820 0 2 0 1 yes
Both uncorrected (Stouffer-Liptak-Kechris) p values and p values corrected for multiple testing (Sidak) are shown, as well as the rank order of the DMR obtained
using the DMRcate method
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one had a low success rate (CpG_4). Correlations be-
tween pregnancy anxiety and DNA methylation of the
GABBR1 DMR were not significant in the total sample
set (mean GABBR1 DMR methylation: Pearson R = 0.100,
p = 0.379). However, as DNA methylation at several
GABBR1 CpG units was associated with the pregnancy
anxiety x gender interaction term (CpG_8 p = 0.045,
CpG_9.10 p = 0.014, CpG_14.15 p = 0.029, and a trending
effect at CpG_3 p = 0.06), data were stratified by gender.
When analyzing the EpiTYPER data for this GABBR1 sep-
arately for male and female newborns, we observed a posi-
tive correlation between fetal GABBR1 DNA methylation
and pregnancy anxiety in male newborns on average
across the amplicon (Pearson R = 0.332, p = 0.039), at
CpG_6, CpG_8, CpG_9.10, CpG_14.15, and a trend was
found (p < 0.1) at CpG_1.2, CpG_16, and CpG_17
(Table 3). Only single CpG units CpG_8 (Pearson
R = 0.517, p = 0.002) and CpG_14.15 (Pearson R = 0.462,
p = 0.003) remained significant following Bonferroni
correction for multiple tests (at α = 0.0056) (Fig. 2).
GABBR1 DNA methylation significantly correlates with
HPA axis function
Using EpiTYPER data (n = 80), we aimed to assess
whether the DNA methylation changes in the GABBR1
DMR are also functionally relevant. For this, we exam-
ined how cord blood GABBR1 DNA methylation relates
to cortisol levels during a stress response at 2 and
4 months and to the cortisol awakening response at
12 months of age. Information on the raw data of these
cortisol measurements can be found in Additional file 1:
Figure S3. At 2 and 4 months, infants were exposed to a
physical stressor, more specifically a routine vaccination
injection. Each time, five saliva samples were taken to
measure the cortisol levels and calculate the elicited
stress response. A paired t test confirmed a significant
cortisol increase between T0 and 15 min at 2 months
(p = 0.002) and 4 months (p < 0.001). At 2 months, one
CpG unit was associated with the initial cortisol re-
sponse to the stressor. At 4 months, several CpG units
appeared to be associated with the AUCi, initial response
Fig. 1 Manhattan plot showing the −log10 p values for all CpG probes and their genomic locations included in the genome-wide methylation analysis
(n = 414,733). The false discovery rate p value threshold is represented by a horizontal line. Vertical lines and overlaid bold dots correspond to
differentially methylated regions (DMRs) identified by comb-p, as represented in Table 2 [25]
Table 3 Pearson correlations of pregnancy anxiety (PRAQ) integrity scores with cord blood GABBR1 DNA methylation (average and
separate CpG units) generated by EpiTYPER, for boys (n = 39) and girls (n = 41) separately
GABBR1 DNA methylation
CpG_1.2 CpG_3 CpG_6 CpG_8 CpG_9.10 CpG_11 CpG_14.15 CpG_16 CpG_17 Average GABBR1
Boys (n = 39) Pearson R 0.302 0.184 0.37 0.517a 0.37 0.156 0.462a 0.295 0.299 0.33
p value 0.061 0.306 0.043 0.002 0.023 0.395 0.003 0.095 0.086 0.039
Girls (n = 41) Pearson R − 0.029 − 0.288 0.032 0.035 − 0.192 − 0.128 − 0.040 − 0.078 − 0.106 − 0.049
p value 0.860 0.093 0.858 0.844 0.278 0.451 0.824 0.655 0.531 0.761
aSignificant after correction for tests at nine CpG sites (α = 0.0056)
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and recovery slope (Table 4). However, following mul-
tiple testing corrections for 27 tests at each study mo-
ment (α = 0.0019), only the following associations
remained. At 4 months, DNA methylation at CpG_1.2
was significantly associated with the initial response
(Pearson R = 0.392, p = 0.001). This same CpG unit was
significantly associated with the recovery slope at
4 months (Pearson R = 0.400, p = 0.001; Table 4).
At 12 months, salivary cortisol levels of infants were
measured to calculate cortisol awakening responses.
However, performing a paired t test indicated that there
was no significant increase in cortisol between awaken-
ing and 30 min (mean difference = − 0.009, p = 0.647).
This is also apparent from Additional file 5: Figure S3B
and S3C. Since there was no significant awakening re-
sponse found, association analyses with GABBR1 DNA
methylation levels were not carried out.
Discussion
In our PELS cohort, we found that prenatal exposure to
maternal pregnancy-related anxiety is associated with
region-specific DNA methylation changes across the
Fig. 2 Correlations for male (blue; n = 39) and female (green; n = 41) newborns between pregnancy anxiety (PRAQ) integrity scores and GABA-B
receptor subunit 1 gene (GABBR1) DNA methylation at a the most significant CpG site (CpG_8) and b on average across the DMR
Table 4 Pearson correlations of cord blood GABBR1 DNA methylation (average and separate CpG units) with infant HPA axis cortisol
measurements in response to routine vaccination at 2 and 4 months of age
GABBR1 DNA methylation
Child HPA axis stress response CpG_1.2 CpG_3 CpG_6 CpG_8 CpG_9.10 CpG_11 CpG_14.15 CpG_16 CpG_17 Average GABBR1
2 M (n = 20) AUCi Pearson R 0.372 − 0.476 0.029 − 0.452 0.109 0.062 0.375 0.238 0.218 − 0.152
p value 0.141 0.053 0.924 0.091 0.678 0.826 0.153 0.375 0.418 0.547
Initial response Pearson R 0.141 − 0.47 0.092 − 0.270 0.120 − 0.004 0.448 0.125 0.172 − 0.098
p value 0.565 0.043 0.745 0.295 0.624 0.989 0.062 0.621 0.494 0.680
Recovery slope Pearson R 0.141 − 0.283 0.063 − 0.162 0.118 − 0.103 0.342 − 0.012 0.083 − 0.086
p value 0.576 0.255 0.830 0.550 0.641 0.716 0.179 0.964 0.751 0.727
4 M (n = 67) AUCi Pearson R 0.260 0.239 0.241 0.200 0.084 0.096 0.080 0.186 0.082 0.168
p value 0.041 0.079 0.091 0.150 0.538 0.487 0.553 0.177 0.547 0.189
Initial response Pearson R 0.392a 0.215 0.35 0.3 0.166 0.184 0.077 0.160 0.136 0.202
p value 0.001 0.102 0.009 0.023 0.210 0.166 0.556 0.230 0.301 0.100
Recovery slope Pearson R 0.400a 0.219 0.38 0.35 0.209 0.27 0.130 0.192 0.182 0.225
p value 0.001 0.102 0.005 0.010 0.115 0.047 0.327 0.159 0.173 0.071
aSignificant at the α level of 0.0019, corrected for 27 tests (3 cortisol variables and 9 CpG sites)
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genome. Previously, we have shown that pregnancy anx-
iety is linked to fetal DNA methylation in the glucocortic-
oid receptor gene (NR3C1), which is a key player in the
hypothalamic-pituitary-adrenal axis, and to DNA methyla-
tion of imprinted genes IGF2 and GNASXL important in
fetal growth and development [14, 15]. This led us to
hypothesize that PRAQ measurements, more specifically
the “fear of integrity” subscale, could indeed have more
widespread associations with fetal DNA methylation.
DNA methylation of repetitive sequences such as
LINE elements have been associated with growth trajec-
tories and birthweight [31]. However, in our study, glo-
bal fetal DNA methylation was not different in the high
versus low prenatal anxiety group and these groups did
not cluster together.
Pathway and GO analysis using ErmineJ [24] results of
the current study should be interpreted carefully, taking
into account the multifunctionality scores of each GO
term. High multifunctionality scores indicate that many
genes involved have several different biological func-
tions, complicating interpretation of these results. Our
findings showed that the top-ranked DMRs annotated to
genes identified in our study were enriched in pathways
related to brain development, general cellular functions,
and tight junctions.
We based the selection of the GABBR1 gene for fur-
ther validation on the merged analysis from both
DMRcate and comb-p, two methods that use different
strategies to identify DMRs using HM450 data. Al-
though absolute DNA methylation differences appeared
small, Cohen’s d effect sizes in the region were medium
to large. Additionally, small absolute differences have
previously been found to be relevant and correlated to
biologically meaningful measurements [32, 33]. Interest-
ingly, the EpiTYPER validation study of the GABBR1
DMR on the full PELS cohort confirmed a gender-
specific association of pregnancy anxiety with GABBR1
DNA methylation. More specifically, in male neonates,
CpG_8 and CpG_14.15 were significantly associated with
pregnancy anxiety following multiple testing corrections,
with a large effect size (Pearson correlation coefficients
R = 0.517 and 0.462, respectively). None of the GABBR1
DMR CpG units were significantly associated with preg-
nancy anxiety in female newborns. A possible explan-
ation for the gender differences might be that the
exposure to an adverse environment is processed in a
different way by both genders. Already during fetal de-
velopment differences in vulnerability to a range of dis-
eases, including psychiatric disorders, arise between
males and females [34] while susceptibility as well as
presentation and therapeutic outcomes appear to be
gender-specific for certain psychiatric disorders later in
life [35]. Evidence from rodent and human research also
indicates that the influence of prenatal environment on
neurodevelopment is modulated by sex [36, 37]. Finally,
gender-specific DNA methylation trajectories were
found during fetal neurodevelopment [38], suggesting
that gender is an important factor to take into account
in analyses similar to the current study.
The identified candidate gene GABBR1 encodes a G-
protein coupled receptor subunit GABA-B1, which het-
erodimerizes with the GABA-B2 subunit to form the
GABA-B receptor. Gamma-aminobutyric acid (GABA)
can reduce neuronal excitability in the central nervous
system by binding these GABA-B or the GABA-A recep-
tors. GABA signaling has a crucial, yet complex, role in
the neuroendocrine adaptation and neuronal plasticity in
response to stress, mainly in the paraventricular nucleus
of the hypothalamus [39]. GABAergic neurotransmission
has been implicated in many psychiatric disorders, in-
cluding anxiety, depression, and schizophrenia [40].
Compelling recent research reveals GABBR1 methyla-
tion changes in HM450 data of a high-risk population of
youths exposed to childhood maltreatment and further
suggests that the identified markers may provide
evidence for a molecular link between early life stress
and mental health [41]. DNA methylation of the
GABBR1 gene has further been implicated in obsessive-
compulsive disorder (OCD) [42] as well as schizophrenia
[43]. In female OCD patients, GABBR1 DNA methyla-
tion was found to be different from healthy controls and
associated with symptom severity at baseline, effect of
treatment, and responder status. In rats, NR3C1 DNA
methylation changes have been found in the hippocam-
pal tissue of rat pups exposed to poor maternal care,
which eventually displayed poor maternal care them-
selves and were more anxious in adult life. Furthermore,
maternal care and early life stress in rats were linked to
the GABAergic synapse and altered GABA-A receptor
expression [44]. In the current study, we identified
GABBR1 DNA methylation as affected by prenatal anx-
iety exposure in a birth cohort. Interestingly, using data
from a previous study, one of our co-authors (DvdH)
found that the hippocampal tissue of female rat pups ex-
posed to prenatal stress showed a 36% decrease in Gabbr1
gene expression. In general, gene expression in these pups
showed an involvement of GABAergic neurotransmission
[45]. We hypothesize that the GABAergic network, in par-
ticular GABBR1, could play an important role in prenatal
stress and that regulation via GABBR1 DNA methylation
may potentially influence HPA axis response.
Furthermore, we showed that fetal GABBR1 DNA
methylation at CpG_1.2 was associated with HPA axis
reactivity in response to a routine vaccination at
4 months old. The observation that we find significant
associations of GABBR1 DNA methylation with stress
response at 4 months but not at 2 months is likely due
to the smaller sample size at 2 months of age, when only
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20 out of 80 mother-child dyads participated. The lack
of significant associations with infant cortisol day pro-
files at 12 months could be due to the fact that we could
not observe an awakening response. Most likely, an in-
crease of cortisol between awakening and 30 min could
not be observed because infants were already lying
awake for some time before the mothers could obtain
the first cortisol sample of the day.
When comparing previously published EpiTYPER
DNA methylation data of NR3C1-1F, IGF2, and
GNASXL regions to the current HM450 data, we noticed
that most analyzed CpG sites were not present on the
HM450 chip. In the IGF2-DMR0 region, no probes were
present. The GNASXL and NR3C1-1F regions were rep-
resented by one and five probes, respectively, which
were not significant.
Some limitations to our current study should be ac-
knowledged. First, the sample size of our genome-wide
study is relatively small and therefore no CpG sites sur-
vived multiple testing corrections at the probe-by-probe
(DMP) analysis level, which is often the case in similar
studies where expected effect sizes are small [46, 47]. In-
stead, we focused on the validation of our findings by
examining nearby CpG sites in a DMR analysis, add-
itionally performing a validation study of our candidate
gene region using EpiTYPER. Moreover, this current
study was intended as a hypothesis-generating study in
which we identified and validated GABBR1 as a gene of
interest, which was consistent with findings in prenatally
stressed rodent brain tissue and associated with infant
phenotype, i.e., HPA axis response. Second, we observe a
cortisol peak at 15 min post-vaccination, as found by
Lewis and Thomas [18]. However, as we have measured
cortisol at 15, 30, 45, and 60 min following vaccination,
we are presumably not measuring the highest cortisol
response peak which is at 20–25 min post-stressor, by
consensus [48, 49]. Yet, it is reasonable to assume that
the AUC and slope values do reflect the inter-individual
variability in cortisol response. Also, the fact that we
could not observe an awakening response at 12 months is a
major limitation for this part of the study. A delay in sam-
pling at awakening and diurnal sampling during only 1 day
likely limit the validity of this measurement. Third, we
examine DNA methylation patterns in umbilical cord blood
samples in response to pregnancy anxiety. There has been
much debate on whether peripheral blood samples can be
used as a surrogate tissue to study brain-related pheno-
types. Although DNA methylation indeed shows tissue-
specific differences [50], several published studies report
valuable DNA methylation differences associated with
disease found in peripheral tissues [51–53]. Moreover, data
from the online Blood Brain DNA Methylation Com-
parison Tool [54] suggested that DNA methylation of the
HM450 probes in the identified GABBR1 DMR was
correlated between peripheral blood and prefrontal cortex
samples (most significant probe: cg05812266, R = 0.425,
p = 0.00012). Furthermore, when analyzing genome-wide
DNA methylation data from peripheral blood samples, it is
important to take blood cell type composition into account,
as these can vary between individuals and may confound
associations of exposure [55]. A number of recent meth-
odological studies question the validity of applying the
Houseman algorithm [23] to cord blood samples for blood
cell type correction [56–58]. However, the method has been
extensively used in genome-wide DNA methylation studies
using DNA from umbilical cord blood [59–66]. The House-
man algorithm estimations remain an approximate calcula-
tion, although they are a good alternative to correct for the
potential influence of cell type composition in the absence
of actual cell type measurements. The results presented in
the current study should be interpreted with caution, taking
these limitations into account.
Conclusions
In conclusion, we showed that pregnancy anxiety is as-
sociated with fetal DNA methylation changes, identifying
GABBR1 as one of the top candidate genes associated
with pregnancy anxiety in male newborns. We further
provide evidence for a potential link of GABBR1 DNA
methylation with infant HPA axis reactivity to a stressor.
Future longitudinal studies performed on larger cohorts
are needed to verify and further explore these findings.
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